Product Program year 2020 Source: CMS Open Payments

Prm_Promacta_Oncology

Drug Oncology

NDC 0078-0686-15

Open in the dashboard

General payments

$33,505

15 payments

Research payments

$0

0 payments

Through program year 2020, $33,505 in general payments and $0 in research payments were reported against Prm_Promacta_Oncology (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $26,917 7
2019 General $6,588 8

Breakdown

Who paid General payments · program years 2019–2020
  1. Novartis Pharma AG $33,505 15 payments
Top recipients General payments · program year 2020
  1. Gerald Soff Hematology & Oncology · Miami, FL $6,000 22% · 1 payment
  2. David Kuter Hematology · Boston, MA $5,502 20% · 1 payment
  3. Eric Winer Hematology & Oncology · Boston, MA $3,930 15% · 1 payment
  4. Balazs Halmos Hematology & Oncology · Cleveland, OH $3,275 12% · 1 payment
  5. Saroj Vadhan-Raj Medical Oncology · Houston, TX $3,275 12% · 1 payment

The top 5 of 7 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Hematology & Oncology Internal Medicine $13,205 49% · 3 practitioners
  2. Medical Oncology Internal Medicine $5,750 21% · 2 practitioners
  3. Hematology Internal Medicine $5,502 20% · 1 practitioner
  4. Gynecologic Oncology Obstetrics & Gynecology $2,460 9% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Massachusetts $9,432 35% · 2 recipients
  2. New York $6,000 22% · 1 recipient
  3. Ohio $5,735 21% · 2 recipients
  4. Texas $3,275 12% · 1 recipient
  5. Minnesota $2,475 9% · 1 recipient

Each share is of general payments naming this product in 2020 where a state was reported.

15 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record